High antagonist potency of GT-2227 and GT-2331, new histamine H 3 receptor antagonists, in two functional models

Author： Tedford C.E. Hoffmann M. Seyedi N. Maruyama R. Levi R. Yates S.L. Ali S.M. Phillips J.G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.351, Iss.3, 1998-06, pp. : 307-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histamine H₃ receptor antagonists

By Tozer M.J. Kalindjian S.B.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1045-1055

Informa Healthcare

Access to resources Recommend Favorite

New potent histamine H 3 -receptor antagonists of the amide type

By Stark H. Lipp R. Arrang J.-M. Garbarg M. Ligneau X. Schwartz J.-C. Schunack W.

European Journal of Pharmaceutical Sciences, Vol. 3, Iss. 2, 1995-04 ,pp. : 95-104

Elsevier

Access to resources Recommend Favorite

Effects Of A Selective Histamine H<sub>4</sub>R Antagonist On Inflammation In A Model Of Carrageenan-Induced Pleurisy In The Rat

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1338-1344

Bentham Science Publishers

Access to resources Recommend Favorite

Dynamics of histamine H 3 receptor antagonists on brain histamine metabolism: do all histamine H 3 receptor antagonists act at a single site?

By Barnes W. Boyd D. Hough L.

European Journal of Pharmacology, Vol. 431, Iss. 2, 2001-11 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

New developments around histamine H₃ receptor antagonists/inverse agonists: a patent review (2010 – present)

By Łażewska Dorota Kieć-Kononowicz Katarzyna

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 89-111

Informa Healthcare

Access to resources Recommend Favorite